Agency Registration Certificate (MOC) for SFDA Drug Registration: What It Is and How to Get It

The Agency Registration Certificate is the Ministry of Commerce's confirmation that a commercial agency or distribution agreement between a foreign principal and a Saudi agent has been registered in the Kingdom's commercial agencies register, as required under the Saudi Commercial Agencies Law. It documents who the appointed local agent is, which principal they represent, and the scope of that representation.

In the drug registration context, the SFDA requires this certificate as evidence that the foreign marketing authorization holder (MAH) has a legally established local agent in Saudi Arabia — the entity through which the SDR application is submitted and through which the SFDA communicates.

No foreign company can hold an SFDA drug registration directly. Applications must be filed by a locally licensed entity, and the SFDA needs proof that the relationship between the foreign MAH and that local entity is formal, current, and legally registered — not just a commercial arrangement on paper. The MOC certificate provides that proof. For the wider process, see our step-by-step guide to SFDA drug registration in Saudi Arabia.

This is why the document appears in SDR requirement checklists alongside the SFDA-issued licenses: the SFDA license establishes that the agent may conduct pharmaceutical activities, while the MOC certificate establishes that the agent is authorized to represent this specific principal.

Foreign manufacturers and MAHs without a legal entity in Saudi Arabia need the certificate for their appointed agent before drug registration can proceed. The local agent must hold a valid Commercial Registration (CR) covering the relevant activity and the appropriate SFDA establishment license.

Companies with their own Saudi subsidiary or scientific office follow a different evidentiary route, since they act in their own name rather than through a commercial agent — but the local entity must still hold the correct SFDA licensing for the products concerned.

The sequence matters, because each step depends on the documents produced by the previous one:

Most delays traced to this document come from consistency errors rather than missing paperwork. The company names on the agency agreement, the agent's CR, the SFDA establishment license, and the SDR application must match exactly — a trading name in one place and a legal name in another is enough to trigger a query. Other recurring problems include expired certificates at the time of SFDA review, agreements whose product scope does not cover the dossier being submitted, and unlegalized or poorly translated agreements that the MOC will not register.

A related requirement trips up trading companies: the SFDA recognizes as MAH the product owner linked to manufacturing, and expects the MAH named in the application to be connected to a manufacturing site registered with the SFDA. A commercial intermediary with no registered site cannot simply name itself MAH — the application structure must reflect the real product owner. Our guide to MAH requirements in Saudi Arabia explains who can hold a Saudi marketing authorization.

MRG supports foreign manufacturers through the full local-representation setup: structuring the agency agreement so its scope matches the intended registrations, coordinating legalization and MOC registration, verifying name and license consistency across the CR, SFDA licenses, and the SDR file, and acting as your regulatory bridge to the SFDA through our pharmaceutical regulatory services — with SFDA Consultation Office license CO-2023-FO-0022 and offices in Saudi Arabia, the UAE, and Egypt.

If your drug registration is blocked on agency documentation, talk to our consultants before resubmitting — consistency fixes are fast, but only when made in the right order.